Diagnostics (Oct 2021)

Development of a Multiplex Loop-Mediated Isothermal Amplification Assay for Diagnosis of <i>Plasmodium</i> spp., <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i>

  • Woong Sik Jang,
  • Da Hye Lim,
  • YoungLan Choe,
  • Hyunseul Jee,
  • Kyung Chul Moon,
  • Chaewon Kim,
  • Minkyeong Choi,
  • In Su Park,
  • Chae Seung Lim

DOI
https://doi.org/10.3390/diagnostics11111950
Journal volume & issue
Vol. 11, no. 11
p. 1950

Abstract

Read online

Malaria, caused by the parasite Plasmodium and transmitted by mosquitoes, is an epidemic that mainly occurs in tropical and subtropical regions. As treatments differ across species of malarial parasites, there is a need to develop rapid diagnostic methods to differentiate malarial species. Herein, we developed a multiplex malaria Pan/Pf/Pv/actin beta loop-mediated isothermal amplification (LAMP) to diagnose Plasmodium spp., P. falciparum, and P. vivax, as well as the internal control (IC), within 40 min. The detection limits of the multiplex malaria Pan/Pf/Pv/IC LAMP were 1 × 102, 1 × 102, 1 × 102, and 1 × 103 copies/µL for four vectors, including the 18S rRNA gene (Plasmodium spp.), lactate dehydrogenase gene (P. falciparum), 16S rRNA gene (P. vivax), and human actin beta gene (IC), respectively. The performance of the LAMP assay was compared and evaluated by evaluating 208 clinical samples (118 positive and 90 negative samples) with the commercial RealStar® Malaria S&T PCR Kit 1.0. The developed multiplex malaria Pan/Pf/Pv/IC LAMP assay showed comparable sensitivity (100%) and specificity (100%) with the commercial RealStar® Malaria S&T PCR Kit 1.0 (100%). These results suggest that the multiplex malaria Pan/Pf/Pv/IC LAMP could be used as a point-of-care molecular diagnostic test for malaria.

Keywords